Company attributes
Other attributes
DiscGenics is a clinical-stage biopharmaceutical company that focuses on developing regenerative cell-based therapies that relief pain and restore function in patients who suffer from degenerative diseases of the spine.
The mission of DiscGenics is to improve the lives of those debilitated by degenerative diseases of the spine via the development of innovative regenerative therapies. The company is committed to achieving this mission by delivering quality products that meet up to or exceed the expectations and requirements of customers.
DiscGenics is led by a team of medical device and biologics industry executives, practicing clinicians and innovators in orthopedics, spinal and neurosurgical markets.
DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what it believes will be a profound therapeutic option for millions of patients who suffer from the effects of low back pain.
